Page last updated: 2024-10-23

azathioprine and Bilateral Deafness

azathioprine has been researched along with Bilateral Deafness in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
" Systemic treatment usually begins with high dosage corticosteroids."1.42Atypical Cogan's syndrome: a case report and summary of current treatment options. ( Jančatová, D; Komínek, P; Matoušek, P; Zeleník, K, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jančatová, D1
Zeleník, K1
Komínek, P1
Matoušek, P1

Other Studies

1 other study available for azathioprine and Bilateral Deafness

ArticleYear
Atypical Cogan's syndrome: a case report and summary of current treatment options.
    International journal of pediatric otorhinolaryngology, 2015, Volume: 79, Issue:3

    Topics: Adolescent; Azathioprine; Cogan Syndrome; Female; Glucocorticoids; Hearing Loss, Bilateral; Hearing

2015